💉
Rectal Bleeding — Adult presentation in primary care Covers fresh PR bleeding, melaena, occult blood, and haematochezia · Adults ≥18 · UK NHS pathway
Progress 0 / 9

⚡ Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen ↗
01
Safety

Red Flags — Haemodynamic instability and cancer must be excluded immediately

Do not assume benign cause. Rectal bleeding is common and usually benign, but colorectal cancer, IBD and significant anorectal disease must not be missed — risk rises with age, persistent bleeding, altered bowel habit, IDA, weight loss, a mass or a positive FIT.
Haemodynamic shock Instability judged clinically (shock index HR/SBP >1 suggests it — BSG), pallor, cold extremities, confusion, syncope → 999 (major lower GI haemorrhage, aortoenteric fistula). Do not delay for PR, FIT or bloods
Melaena Usually upper GI (occasionally small bowel or right colon); brisk upper GI bleeding can also present as fresh PR blood → same-day hospital (A&E) assessment, 999 if unstable; the hospital team risk-stratifies and arranges endoscopy
Haematochezia with shock Profuse fresh rectal bleeding + haemodynamic instability → 999 (massive lower GI bleed, Meckel's, ischaemic colitis)
Age ≥50 unexplained rectal bleeding With or without change in bowel habit → offer FIT; FIT ≥10 µg Hb/g → suspected cancer pathway referral (NICE NG12, updated April 2026)
Change in bowel habit (any adult age), or under 50 with bleeding plus abdominal pain or weight loss → offer FIT; ≥10 µg Hb/g → suspected cancer pathway (NG12/HTG690). FIT is triage: a low result with persistent or concerning bleeding still needs a colorectal pathway (ACPGBI/BSG)
Iron-deficiency anaemia + rectal bleeding Confirm with iron studies; FIT helps prioritise (≥10 → suspected cancer pathway) but a low FIT does not exclude investigation — men and post-menopausal women generally need upper and lower GI assessment (BSG 2021; BSG/ACPGBI 2025)
Palpable rectal or abdominal mass On examination → rectal mass, unexplained anal mass or unexplained anal ulceration: consider a suspected cancer pathway referral without waiting for FIT (NICE NG12); abdominal mass: FIT first (NICE NG12 / HTG690) and the site-specific NG12 route
Unexplained weight loss + rectal bleeding Any unexplained weight loss → offer FIT (NG12: under 50 with rectal bleeding and weight loss; 40 and over with weight loss and abdominal pain). FBC and ferritin; other bloods by indication (CEA is not a diagnostic test)
Persistent or recurrent rectal bleeding Despite an apparent benign explanation (e.g. haemorrhoids), at any age → investigate further before attributing it to a benign cause
Family history colorectal cancer Document number, ages and cancer types (including endometrial/Lynch-spectrum) → local hereditary CRC/genetics criteria; it lowers the threshold for colonoscopy but does not replace examination and the symptomatic FIT pathway
Colorectal cancer is the 4th most common cancer in the UK and the 2nd most common cause of cancer death. NICE NG12 sets its referral thresholds at a positive predictive value of 3% or more, so most people referred will not have cancer — but the threshold is deliberately low. Critically, haemorrhoids are very common — the dangerous error is attributing bleeding to haemorrhoids without excluding more serious pathology. Upper GI bleeding presenting as melaena can be fatal — hospital risk-stratification (Glasgow-Blatchford score) drives urgency). Never assume bright red blood = haemorrhoids alone without appropriate assessment.
02
Diagnose

Characterise the bleeding — colour, site, pattern, and associations narrow diagnosis

Colour and character
Bright red, on paper / separate = likely anorectal (haemorrhoids, fissure) · Mixed with stool = more proximal (polyp, cancer, IBD, diverticular) · Dark red / maroon = right colon / small bowel source · Melaena (black, tarry) = usually upper GI (occasionally small bowel or right colon) · Occult (FIT positive) = any site
Volume
Drops / spots = anorectal. Coating stool = distal. Significant volume mixed in bowl = proximal. Gushes = diverticular or angiodysplasia. Quantify in practical terms: teaspoon / tablespoon / toilet bowl
Associated symptoms
Pain on defaecation = fissure · Painless = haemorrhoids / cancer · Mucus = IBD, rectal cancer, solitary rectal ulcer · Tenesmus (persistent urge) = rectal cancer, IBD · Diarrhoea + bleeding = IBD, infectious, cancer
Systemic symptoms
Fever = IBD flare, infectious colitis, diverticulitis · Weight loss = cancer · Fatigue / pallor = anaemia (may indicate chronic slow bleed)
Bowel habit change
Change in bowel habit at any adult age = offer FIT (NICE NG12, updated April 2026). Alternating diarrhoea/constipation with bleeding = IBS unlikely — investigate
Temporal pattern
Acute single episode = diverticular / angiodysplasia / trauma · Recurrent intermittent = haemorrhoids, polyps, cancer · Chronic continuous = IBD, cancer, fistula
Risk factors
Age, NSAIDs / anticoagulants (raise diverticular bleed risk), IBD diagnosis, previous polyps, constipation, anal intercourse, recent instrumentation, travel (infectious colitis)
The colour and distribution of blood is the single most important clinical discriminator. Bright red blood on the paper or separate from stool (rather than mixed) usually indicates an anorectal source. However, some still have more proximal pathology. Melaena usually indicates an upper GI source but can arise from the small bowel or right colon, and a brisk upper GI bleed can present as fresh red blood — assess the whole patient rather than stool appearance alone. NSAIDs and antithrombotics increase the risk of diverticular bleeding. Always ask about medication.
03
Diagnose

Classify by likely diagnosis — guide workup and referral pathway

Anorectal (most common)
Haemorrhoids (internal grade I–IV, external) · Anal fissure · Fistula-in-ano · Rectal prolapse · Solitary rectal ulcer syndrome. Confirm with PR exam ± proctoscopy where appropriate
Colonic — benign
Diverticular bleed (sudden painless large-volume bleed, often self-limiting, age ≥50) · Angiodysplasia (recurrent small bleeds, elderly, RHF association) · Colonic polyps
Colonic — inflammatory
IBD (Crohn's / UC — bloody diarrhoea, systemic symptoms, age <40 commonest) · Infective colitis (acute onset, travel history, fever) · Ischaemic colitis (vascular disease, sudden onset, LIF pain)
Colorectal cancer
Any age but rare <40. Change in bowel habit + bleeding + weight loss. Right-sided = occult blood / anaemia. Left-sided = altered stool + bright blood. Rectal = tenesmus + bleeding
Upper GI (presenting as dark PR blood)
Peptic ulcer · Oesophageal varices · Mallory-Weiss · Aortoenteric fistula (post-AAA repair). If history of AAA repair → 999 (herald bleed precedes exsanguination)
Rare / don't miss
Meckel's diverticulum (young patients, painless, massive) · Radiation proctitis (previous pelvic radiotherapy) · Rectal varices (portal hypertension)
Diverticular bleeding is the most common cause of significant lower GI haemorrhage in adults over 50. It is almost always painless and usually stops spontaneously — but requires hospital assessment and risk stratification (BSG 2019: shock index, Oakland score). Unstable or major ongoing bleeding → emergency admission with CT angiography to localise; stable → hospital investigation with colonoscopy on the next available list. The specialist team decides on transfusion and investigation. Aortoenteric fistula is rare but uniformly fatal without immediate surgery — any patient with prior AAA repair presenting with GI bleeding must be treated as this until excluded. IBD first presentation in primary care is frequently delayed — think of it in any young adult with bloody diarrhoea.
04
Diagnose

Targeted examination — PR exam where appropriate in stable patients

Vital signs + NEWS2
HR, BP (lying and standing — postural drop >20mmHg SBP = significant volume loss), temperature, RR, SpO₂. Pallor, capillary refill. Instability (clinical picture, shock index) → 999; NEWS2 supports, not decides
Abdominal exam
Masses (hepatomegaly — liver mets; abdominal mass — tumour, diverticular phlegmon) · Tenderness · Distension · Bowel sounds. Stigmata of liver disease (spider naevi, caput medusae, ascites) if portal hypertension suspected
Perianal inspection
External haemorrhoids (bluish, tense if thrombosed) · Skin tags · Sentinel pile (fissure marker) · Fistula orifice · Rectal prolapse · Warts (viral — ask re sexual health)
Digital rectal exam (PR)
In a stable patient with consent and chaperone, where it will change management — never delaying emergency transfer; if too painful, document and arrange specialist assessment. Anal tone · Tender fissure · Mass · Fresh blood / melaena on glove · Faecal impaction · Prostate (men)
Proctoscopy (if available)
Visualise internal haemorrhoids (can only be seen with proctoscope, not finger) · Anal fissure · Low rectal lesion. Can be done in practice with appropriate equipment and training
Lymph nodes
Inguinal lymphadenopathy (anal/lower rectal cancer, STI) · Supraclavicular (Virchow's node = upper GI / left colon metastases)
In a stable patient, with consent and a chaperone, PR examination can detect a low rectal or anal mass and should be done where clinically appropriate; never delay emergency transfer for it, and document if it was too painful and arrange specialist assessment. Internal haemorrhoids (the most common cause of bright PR bleeding) cannot be seen or felt on PR exam alone — they require proctoscopy. Postural drop (orthostatic hypotension) identifies occult haemodynamic compromise in patients appearing well supine — check it in any patient with significant rectal bleeding.
05
Diagnose

Investigations — FIT test is now the pivotal primary care investigation

By indication
FBC (persistent/recurrent or significant bleeding, suspected anaemia) Ferritin (if anaemia/iron deficiency suspected) U&E (significant bleed, dehydration) LFTs + coagulation (liver disease, anticoagulation) CRP (suspected IBD/infection — not routine in isolated bright-red bleeding)
FIT Test (faecal immunochemical test)
FIT ≥10 µg/g → colorectal suspected cancer pathway referral. Quantitative FIT (not the same as FOBT) · NICE NG12 / HTG690 (2023 update): FIT-first now guides referral for nearly all suspected-colorectal-cancer presentations, including rectal bleeding · FIT <10 does not exclude cancer — safety-net and re-refer if symptoms persist or IDA develops
Suspected cancer criteria met
Colorectal suspected cancer pathway referral — FIT-first: use the FIT result to guide referral. Do not wait for FIT with a rectal mass, unexplained anal mass or unexplained anal ulceration — consider a suspected cancer pathway referral directly; clinical judgement can still override a negative FIT where concern remains strong
If IBD suspected
Faecal calprotectin (when IBD suspected after considering infection — interpret per local assay and pathway; not diagnostic) Stool culture/PCR (acute bloody diarrhoea, fever, travel, immunosuppression) Coeliac screen
If STI possible
GUM screen including gonorrhoea / chlamydia rectal swabs, syphilis serology, HIV
Upper GI bleed screen
Group and save (if significant bleed) H. pylori (breath test or stool antigen — if melaena, do after endoscopy) OGD (urgent — via A&E for haemodynamically significant or melaena)
Do NOT
Attribute bleeding to haemorrhoids without age-appropriate assessment · Delay a mass/ulceration referral to await FIT · Repeat FIT to get a "normal" before referring · Discharge a FIT-negative patient with persistent symptoms without safety-netting
FIT (faecal immunochemical test) has replaced FOBT (faecal occult blood test) as the preferred primary care investigation. FIT is more sensitive and specific — it detects human haemoglobin, not animal blood in food. NICE HTG690 recommends FIT to guide colonoscopy need in symptomatic patients. Under the FIT-first pathway, people with rectal bleeding are offered FIT too; only a rectal mass, unexplained anal mass or unexplained anal ulceration skips FIT (NG12: consider a suspected cancer pathway referral directly) — and a negative FIT does NOT fully exclude CRC, so persistent symptoms still need safety-netting and review. Faecal calprotectin helps when IBD is suspected (interpret per local pathway; NICE HTG320).
06
Refer

Referral criteria — rectal bleeding has high suspected cancer referral rate by design

999 Emergency
Haemodynamic instability (shock) · Massive PR haemorrhage · Melaena with haemodynamic compromise · Suspected aortoenteric fistula (post-AAA repair). Call 999 and do not transfer independently
Same-day A&E
Stable melaena (hospital risk-stratifies and arranges endoscopy) · Major or ongoing fresh PR bleed · Significant bleed with major comorbidity or anticoagulation · Acute bleed with significant anaemia. Stable minor self-terminating bleeds: Oakland score (≤8 may suit an urgent outpatient pathway, with other factors considered — BSG)
Suspected cancer: colorectal
NICE NG12: unexplained PR bleeding at 50+ · PR bleeding under 50 with abdominal pain or weight loss · change in bowel habit or IDA at any age · abdominal mass · anaemia at 60+ → offer FIT (≥10 → suspected cancer pathway) · rectal mass, unexplained anal mass or unexplained anal ulceration → consider a suspected cancer pathway referral without FIT · FIT-first (NG12 / HTG690): these symptomatic groups are offered FIT to guide the referral (≥10 µg/g → suspected cancer pathway referral); rectal mass, unexplained anal mass or anal ulceration → consider referral without waiting for FIT
Urgent gastroenterology
Suspected new IBD (bloody diarrhoea, systemic symptoms, elevated calprotectin) · Recurrent significant diverticular bleeding · Ischaemic colitis · Radiation proctitis requiring treatment
Routine colorectal / surgical
Grade III–IV haemorrhoids for banding/surgery · Chronic anal fissure not responding to medical treatment · Fistula-in-ano (complex) · Rectal prolapse requiring surgical repair
GUM clinic
Rectal STI (gonorrhoea, chlamydia, syphilis, herpes proctitis, warts) — refer to sexual health
Primary care manages
Grade I–II haemorrhoids (conservative + topical treatment) · Acute anal fissure (medical management) · Infectious diarrhoea with PR bleeding (self-limiting gastroenteritis — monitor, stool cultures) · FIT <10 µg/g in low-risk patients whose bleeding has settled, with safety-netting (local protocol) — persistent bleeding still needs colorectal assessment
NICE NG12 deliberately sets a low threshold for suspected cancer pathway referral in rectal bleeding — most people referred will have a benign cause. This is intentional: missing CRC carries far greater harm than an unnecessary colonoscopy. The Glasgow-Blatchford score is the hospital tool for risk-stratifying upper GI bleeds (the Oakland score applies to lower GI bleeds) and predicts need for intervention (endoscopy, blood, surgery); it is not a primary-care admission rule. Grade III haemorrhoids (require manual reduction) and grade IV (irreducible) almost always need surgical referral — topical treatment is ineffective at this stage.
07
Treat

Treatment — condition-specific; primary care manages benign anorectal causes

Haemorrhoids (Grade I–II)
Topical + lifestyle 1st line
Short course of one topical steroid/anaesthetic preparation (about 5–7 days, per product SPC; sensitisation and atrophy with prolonged use) · High-fibre diet · Adequate hydration · Avoid straining
Anal fissure (acute)
Conservative first; GTN or diltiazem if persistent 1st line
Acute: stool softening, fibre, fluids, analgesia, short topical anaesthetic. Persistent/chronic: GTN 0.4% (licensed; headache; not with PDE-5 inhibitors or hypotension) or diltiazem 2% (unlicensed — document consent) for about 8 weeks
Established UC
Follow the specialist plan Under specialist
Do not treat undiagnosed bleeding as UC. Flares per the shared-care plan and NICE (topical 5-ASA first for proctitis; escalation including time-limited steroids is clinician-led). Acute severe UC (Truelove and Witts: ≥6 bloody stools a day plus temperature >37.8°C, HR >90, Hb <105 g/L or ESR >30 mm/h) → same-day hospital admission; other flares with systemic upset, dehydration or severe pain → urgent gastroenterology advice
Haemorrhoids Step 1Topical hydrocortisone / local anaesthetic cream (Anusol HC, Proctosedyl) about 5–7 days max; one preparation at a time; avoid codeine. A bulk-forming or osmotic laxative by stool consistency + fibre to reduce straining. Sitz baths (warm water) for symptom relief
Haemorrhoids Step 2Refer for rubber band ligation (Grade II) for selected internal haemorrhoids. Or injection sclerotherapy (5% phenol in oil). Both performed in outpatient setting without GA
Anal fissure Step 1GTN 0.4% ointment BD to anal margin (not into anal canal) × 8 weeks. Warn: headache common (reduces over 1–2 weeks). Alternatively: Diltiazem 2% cream BD × 8 weeks (unlicensed; fewer headaches). Recurrent, atypical, lateral, multiple or non-healing → reassess for Crohn's, malignancy, infection or trauma
Anal fissure Step 2Failed medical treatment → Refer surgical for botulinum toxin or lateral internal sphincterotomy (specialist discussion of benefits and incontinence risk)
Diverticular bleedMajority self-terminate. Primary care action: unstable or major ongoing bleeding → emergency admission (999), where CT angiography is used to localise the bleeding; stable but significant bleeding → same-day hospital assessment, where it is investigated with colonoscopy on the next available list (BSG 2019) — no fixed colonoscopy time applies in primary care. In hospital: IV access, FBC/group & save, risk stratification (shock index; Oakland score). Do not use FIT to judge the severity or source of an acute diverticular bleed — follow the acute LGIB pathway. After stabilisation, arrange colorectal investigation by age, severity, anaemia, recurrence and cancer risk. Review NSAIDs and antithrombotics
Anticoagulated patientDo not withhold anticoagulation without specialist advice — thrombotic risk may exceed bleeding risk. Discuss with anticoagulation clinic / cardiologist. Manage bleed urgency as per clinical status. Refer to A&E if significant bleeding

Next steps: see Haemorrhoids · Anal fissure · Diverticular disease · Ulcerative colitis · Crohn's disease

GTN 0.4% ointment works by relaxing the internal anal sphincter (reducing hypertonia that impairs fissure healing) — it improves healing compared with lidocaine alone. Diltiazem 2% cream (unlicensed) has similar efficacy with fewer headaches. Rubber band ligation is an effective outpatient option for selected internal haemorrhoids. Topical steroids should not be used for more than 7 days continuously (atrophy, infection risk). Review NSAIDs and antithrombotics after a diverticular bleed, following local analgesia and gastroprotection guidance.
08
Lifestyle

Non-pharmacological — prevent recurrence and reduce risk of serious pathology

High-fibre diet 25–30g fibre/day. Softens stool and reduces straining. Wholegrain, fruit, vegetables daily
Adequate hydration Adequate fluid, tailored to comorbidity. Essential to prevent hard stools — the primary mechanical cause of haemorrhoids and anal fissures from straining
Defaecation posture Never strain or spend prolonged time on toilet. Respond immediately to defaecation urge
Bowel habit regularity Regular toileting routine (post-breakfast — gastrocolic reflex). Avoid constipation proactively. Treat constipation before it causes haemorrhoidal disease
Weight management Obesity increases intra-abdominal pressure → worsens haemorrhoids and diverticular disease. Refer to weight management where appropriate
Physical activity Regular activity is protective. Reduces constipation, diverticular disease, and obesity-related comorbidities
NSAID and anticoagulant review NSAIDs raise diverticular bleed risk. Review the indication and follow local analgesia/gastroprotection guidance
Bowel cancer screening Ensure enrolled in NHS Bowel Cancer Screening Programme (FIT every 2 years from age 50, colonoscopy if positive). A previous negative screening FIT does not reassure a symptomatic patient; family history is assessed separately
Alcohol moderation Alcohol increases colorectal cancer risk. Units <14/week for all adults. Alcohol causes liver disease → portal hypertension → rectal varices
Adequate fibre and fluid, avoiding straining and managing constipation are practical measures, tailored to stool consistency and comorbidity. Physical activity is associated with lower colorectal cancer risk, without the bleeding risk. NHS Bowel Cancer Screening reduces bowel cancer mortality — ensuring eligible patients are enrolled and engaged is a primary care quality metric. Alcohol is a recognised WHO Group 1 carcinogen for colorectal cancer — clear, quantified advice should be given at every opportunity.
09
Safety

Follow-up & monitoring — maintain vigilance; rectal bleeding needs structured review

1 week
Acute fissure or haemorrhoids: check response to topical treatment. Blood test results review. If no improvement → reassess and consider referral
4–6 weeks
Fissure on GTN/diltiazem: healing assessment (reduce to OD if improving). FIT result actioned. Any suspected cancer referral acknowledgment received from secondary care
8 weeks
End of fissure treatment course: document healing. If incomplete → refer surgical. Haemorrhoid: reassess symptom control — refer if Grade III/IV
Post-colonoscopy
Review results letter. Post-polypectomy surveillance per BSG/ACPGBI/PHE 2020 guidelines (high risk — ≥2 premalignant polyps including ≥1 advanced, or ≥5 premalignant polyps: one-off colonoscopy at 3 years; low risk: no surveillance — return to screening). Communicate results clearly to patient
IBD follow-up
Shared care with gastroenterology. FBC + LFTs 3-monthly on immunomodulators. Surveillance colonoscopy per NICE CG118 (UC beyond proctitis, or Crohn's colitis in more than one segment), timed by disease duration and risk. Drug monitoring per the shared-care protocol
999 Safety-net
Return of haemorrhagic shock · Heavy PR haemorrhage · Collapse, or feeling faint or dizzy with bleeding · Haematemesis · Severe abdominal pain with bleeding
Same-day GP Safety-net
New black, tarry stools (melaena) → same-day A&E, 999 if faint or collapsing · Any return of significant PR bleeding · New weight loss or systemic symptoms · Bleeding not settling after 48–72h · Failure to receive a suspected cancer appointment (per local pathway)
NHS Bowel Screening
Confirm patient enrolled. If previously declined — re-offer. Document screening status in records. Patients with CRC family history may need earlier surveillance — check eligibility criteria
Patients with adenomas found on colonoscopy have an increased risk of future CRC — surveillance intervals (BSG/ACPGBI/PHE 2020 post-polypectomy guidelines) are evidence-based and must be communicated clearly and followed up. IBD patients with extensive colitis have a raised CRC risk that grows with disease duration — surveillance colonoscopy at risk-based intervals (1, 3 or 5 years; NICE CG118, BSG 2019) must be kept on track. Patients who do not receive their suspected cancer referral appointment confirmation within 14 days should be followed up proactively — system failures occur, and the patient cannot always advocate for themselves. A documented safety-net discussion is an RCGP SCA examination competency requirement.
Educational use only. Pathway based on: NICE NG12 (updated April 2026; FIT-first colorectal recommendations) · NICE HTG690 (FIT to guide colorectal referral; formerly DG30 and DG56) · BSG Lower GI Bleeding Guidelines · BSG IBD Guidelines · BSG Colorectal Cancer Screening/Surveillance · NHS Bowel Cancer Screening Programme · WCRF Cancer Prevention Recommendations · ACPGBI/BSG FIT guideline (2022) · BSG iron deficiency anaemia guideline (2021) · BSG/ACPGBI FIT in IDA guidance (2025) · BSG acute lower GI bleeding guideline (2019) · BSG/ACPGBI/PHE post-polypectomy surveillance (2020) · NICE NG130 (Ulcerative colitis) · NICE CG118 (Colonoscopic surveillance) · NICE haemorrhoid interventional guidance. Always adapt to individual patient context and local clinical guidelines.